Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update

Phosphodiesterase isoenzymes 5 inhibitors (PDE5-Is) are the first-line therapy for erectile dysfunction (ED). The constant discoveries of nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) cell-signaling pathway for smooth muscle (SM) control in other urogenital tracts (UGTs) make PDE5-Is promi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wen-Hao, Zhang, Xin-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000795/
https://www.ncbi.nlm.nih.gov/pubmed/26620458
http://dx.doi.org/10.4103/1008-682X.167721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000795/
https://www.ncbi.nlm.nih.gov/pubmed/26620458
http://dx.doi.org/10.4103/1008-682X.167721

Ejemplares similares